The case of Africa's 'vanishing' carbon deals
The case of Africa's 'vanishing' carbon deals

By AFP's Evelyn Kpadeh Seagbeh and Code for Africa's Kunle Adebajo
Jerusalem (AFP) | 26/05/2026 - 20:22:15 | Israel says targeted new Hamas armed wing chief in Gaza strike
Washington (AFP) | 26/05/2026 - 18:51:58 | Trump says medical check-up went 'perfectly'
Paris (AFP) | 26/05/2026 - 18:19:26 | France breaks new May heat record on Tuesday: French weather service
Mexico City (AFP) | 26/05/2026 - 17:47:37 | Mexico captures US-wanted nephew of 'El Chapo' Guzman
Jerusalem (AFP) | 26/05/2026 - 17:06:18 | Israeli forces expand south Lebanon ground operations: military official
London (AFP) | 26/05/2026 - 16:50:56 | Four teenagers drown in England since Sunday in heatwave: local authorities, police
London (AFP) | 26/05/2026 - 16:27:48 | UK has hottest day in May on record at 35C: Met Office
Tehran (AFP) | 26/05/2026 - 16:24:14 | Iran vice president says first steps taken to restore internet after shutdown
United Nations (AFP) | 26/05/2026 - 16:16:52 | Dozens of countries at UN condemn Moscow's 'threats' to embassies in Ukraine
Paris (AFP) | 26/05/2026 - 16:10:14 | Iran sees 'partial restoration' to internet after three-month shutdown: monitor
OKX, a blockchain technology and trading company serving more than 120 million customers globally, and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions whe...

By AFP's Evelyn Kpadeh Seagbeh and Code for Africa's Kunle Adebajo
ChatEurope, the go-to platform for European affairs created by leading European media outlets, enhances its offer with the launch of key EU events live video coverage.
Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/Conceptual Diagram of ...
Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,” said Thomas Fuchs, CEO, Mosaic Therapeutics. “His deep expertise in tar...
Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking licens...
Danube Properties has unveiled Greenz By Danube, its first large-scale integrated community featuring premium townhouses and villas - marking a major milestone in its expansion into master-planned developments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401810554/en/Danube Properties Unveils AED 3.5M+ ‘Greenz’ Master Community in Dubai’s High-Growth Academic City (Photo: AETOSWire) Strategically located in Dubai International...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resi...